Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Danazol in Advanced or Recurrent Endometrial Cancer

NCT00003946 is registered in ClinicalTrials.gov with Gynecologic Oncology Group as lead sponsor.

NCT NCT00003946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Danazol in Advanced or Recurrent Endometrial Cancer
Lead sponsor
Gynecologic Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
August 31, 1999
Completion date
Not reported
Enrollment
Not reported
Sites
73

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer